E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA

[1]  Ming Li,et al.  A Noval Established Cuproptosis-Associated LncRNA Signature for Prognosis Prediction in Primary Hepatic Carcinoma , 2022, Evidence-based complementary and alternative medicine : eCAM.

[2]  Yi-ping Lin,et al.  Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma , 2022, Oncogene.

[3]  Chang Liu,et al.  Alternatively-spliced lncRNA-PNUTS promotes HCC cell EMT via regulating ZEB1 expression , 2022, Tumori.

[4]  Shiqi Gao,et al.  Classification of Hepatocellular Carcinoma Based on N6-Methylandenosine–Related lncRNAs Profiling , 2022, Frontiers in Molecular Biosciences.

[5]  Ye-Ting Lu,et al.  HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway , 2021, Cell Death & Disease.

[6]  Y. Niu,et al.  Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC , 2021, Oncogene.

[7]  X. Gou,et al.  Secretory autophagy-induced bladder tumour-derived extracellular vesicle secretion promotes angiogenesis by activating the TPX2-mediated phosphorylation of the AURKA-PI3K-AKT axis. , 2021, Cancer letters.

[8]  Changwen Bo,et al.  Long non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma progression by stabilizing ILF3 mRNA in an m6A-dependent manner , 2021, Human Cell.

[9]  P. Canoll,et al.  Aurora kinase A inhibition reverses the Warburg effect and elicits unique metabolic vulnerabilities in glioblastoma , 2021, Nature Communications.

[10]  Yan Zhao,et al.  Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1 , 2021, Aging.

[11]  Z. Dong,et al.  Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy , 2021, Molecular cancer.

[12]  F. Ban,et al.  Dual-Inhibitors of N-Myc and AURKA as Potential Therapy for Neuroendocrine Prostate Cancer , 2020, International journal of molecular sciences.

[13]  Qing Yang,et al.  The role of ubiquitination and deubiquitination in cancer metabolism , 2020, Molecular cancer.

[14]  F. Peng,et al.  Oncogenic AURKA-enhanced N6-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cells , 2020, Cell Research.

[15]  J. Schwartz,et al.  Hepatocellular carcinoma: epidemiology, screening, and assessment of hepatic reserve. , 2020, Current oncology.

[16]  O. Wolkenhauer,et al.  LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1 , 2020, Theranostics.

[17]  Z. Dong,et al.  SDCBP/MDA-9/syntenin phosphorylation by AURKA promotes esophageal squamous cell carcinoma progression through the EGFR-PI3K-Akt signaling pathway , 2020, Oncogene.

[18]  Xue Wang,et al.  Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells , 2020, Theranostics.

[19]  Weifeng He,et al.  The role of long noncoding RNAs in hepatocellular carcinoma , 2020, Molecular Cancer.

[20]  Juan Li,et al.  E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway , 2020, Cell Death & Disease.

[21]  Gang Wu,et al.  lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC , 2020, BMC Cancer.

[22]  Yongchang Wei,et al.  Long noncoding RNA SPRY4‐IT1 promotes proliferation and metastasis of hepatocellular carcinoma via mediating TNF signaling pathway , 2020, Journal of cellular physiology.

[23]  Hui Zhang,et al.  MicroRNA-490-3p suppresses hepatocellular carcinoma cell proliferation and migration by targeting the aurora kinase A gene (AURKA) , 2019, Archives of medical science : AMS.

[24]  D. Xie,et al.  circCAMSAP1 Promotes Tumor Growth in Colorectal Cancer via the miR-328-5p/E2F1 Axis. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  Liteng Lin,et al.  LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[26]  Gregory J. Gores,et al.  A global view of hepatocellular carcinoma: trends, risk, prevention and management , 2019, Nature Reviews Gastroenterology & Hepatology.

[27]  G. Leone,et al.  The broken cycle: E2F dysfunction in cancer , 2019, Nature Reviews Cancer.

[28]  Hao-Lian Zhan,et al.  LncRNA MEG3 contributes to adenosine‐induced cytotoxicity in hepatoma HepG2 cells by downregulated ILF3 and autophagy inhibition via regulation PI3K‐AKT‐mTOR and beclin‐1 signaling pathway , 2019, Journal of cellular biochemistry.

[29]  M. Omata,et al.  Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review , 2019, International journal of molecular sciences.

[30]  R. Jia,et al.  Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation , 2019, RNA.

[31]  Honggang Zhou,et al.  USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma , 2019, Theranostics.

[32]  Lingfang Teng,et al.  LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis , 2018, Aging.

[33]  G. dos Santos Fernandes,et al.  Hepatocellular Carcinoma: Review of Targeted and Immune Therapies , 2018, Journal of Gastrointestinal Cancer.

[34]  C. Peng,et al.  EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer. , 2018, Lung cancer.

[35]  Shun-Fa Yang,et al.  Variations in the AURKA Gene: Biomarkers for the Development and Progression of Hepatocellular Carcinoma , 2018, International journal of medical sciences.

[36]  Guangyuan Song,et al.  AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinoma. , 2017, Biochemical and biophysical research communications.

[37]  Matthew S. Johnson,et al.  The diagnosis and treatment of hepatocellular carcinoma. , 1998, Seminars in diagnostic pathology.

[38]  F. Z. Hapil,et al.  E2F1 transcription factor and its impact on growth factor and cytokine signaling. , 2016, Cytokine & growth factor reviews.